DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Lehr T, Haertter S, Liesenfeld KH. et al.
Dabigatran etexilate in atrial fibrillation patients with severe renal impairment: dose identification using pharmacokinetic modeling and simulation.
J Clin Pharmacol 2012;
52 (09) 1373-1378
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.